Phillips Medisize

Two scientists walking in a manufacturing plant in sterile coveralls and face masks demonstrating CDMO quality and regulatory services using laptop computer.

From Dis­cov­ery to De­liv­ery, We Build Trust

As a contract development and manufacturing organization (CDMO), the world’s leading pharmaceutical, medtech and in vitro diagnostic companies trust us to help them design and manufacture their products. Across the US, Europe and Asia, we engage with each customer we are privileged to serve in a tailored, highly personalized way by listening, asking questions and embracing your engineering challenges. That’s because we believe the C in CDMO also represents Care — the Care we take in engineering your products and the Care these devices ultimately deliver to patients.

Bringing possibilities to life.™

Group of clinicians in scrubs and surgical caps in a cleanroom environment collaborating on electrophysiology catheter design, testing and quality review. 
Rethinking Electrophysiology Catheter Design
Discover the core electrical, mechanical and material considerations shaping advanced EP catheters, from design through commercial production.
Learn more
Engineering Advanced Pulsed Field Ablation Technology for Next-Generation Cardiac Catheters
Discover how pulsed field ablation technology is transforming cardiovascular care
Learn more
CDMO
Delivery Minded Thinking: Preserving Meaningful Choices in Drug and Device Development
Explore how early device strategy can shape the treatment experience.
Learn More
A view of the city of Edinburgh during the day
DDL Conference 
Meet Phillips Medisize at Drug Delivery to the Lungs (DDL) 2026 in Edinburgh. Visit booth 166 and learn about our latest research in nebulization, dry powder inhalers (DPIs) and inhaled GLP-1 drug delivery. Learn more.
Boston, Massachusetts, USA Downtown Skyline
PODD 2026
Discover the future of patient-enabled drug delivery at PODD 2026. Join Phillips Medisize in Boston for Iain Simpson’s plenary on moving large-volume therapies beyond the clinic. Learn more.
Phillips Medisize - A Molex Company
Phillips Medisize Acquires Chippenham Facility to Expand Global Inhalation Center of Excellence
Phillips Medisize announces investment to acquire the complete footprint of its Chippenham site. Together with its Cambridge location, the newly acquired facility strengthens the company’s Global Inhalation Center of Excellence (COE) and provides additional capacity to support projected business growth. Learn more.